Sarepta Therapeutics has followed through on its promise to file for accelerated approval of its gene therapy SRP-9001 for Duchenne muscular dystrophy (DMD), as it aims for a launch in the middle of ...
From desk-dominating 6K monitors to input devices that rethink how we click, scroll, and type, CES 2026 proved that the unsung heroes of the PC world—peripherals!—are about to have a breakout year. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results